Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase
Carole Guillonneau, … , Maria Cristina Cuturi, Ignacio Anegon
Carole Guillonneau, … , Maria Cristina Cuturi, Ignacio Anegon
Published April 2, 2007
Citation Information: J Clin Invest. 2007;117(4):1096-1106. https://doi.org/10.1172/JCI28801.
View: Text | PDF
Research Article Article has an altmetric score of 15

CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase

  • Text
  • PDF
Abstract

Treatment with CD40Ig results in indefinite allograft survival in a complete MHC-mismatched heart allograft model in the rat. Here we show that serial second, third, and fourth adoptive transfers of total splenocytes from CD40Ig-treated recipients into secondary recipients led to indefinite donor-specific allograft acceptance. Purification of splenocyte subpopulations from CD40Ig-treated recipients demonstrated that only the adoptively transferred CD8+CD45RClow subset resulted in donor-specific long-term survival, whereas CD8+CD45RClow T cells from naive animals did not. Accepted grafts displayed increased indoleamine 2,3-dioxygenase (IDO) expression restricted in the graft to ECs. Coculture of donor ECs with CD8+CD45RClow T cells purified from CD40Ig-treated animals resulted in donor-specific IDO expression dependent on IFN-γ. Neutralization of IFN-γ or IDO triggered acute allograft rejection in both CD40Ig-treated and adoptively transferred recipients. This study demonstrates for what we believe to be the first time that interference in CD40–CD40 ligand (CD40-CD40L) interactions induces allospecific CD8+ Tregs that maintain allograft survival. CD8+CD45RClow T cells act through IFN-γ production, which in turn induces IDO expression by graft ECs. Thus, donor alloantigen-specific CD8+ Tregs may promote local graft immune privilege through IDO expression.

Authors

Carole Guillonneau, Marcelo Hill, François-Xavier Hubert, Elise Chiffoleau, Caroline Hervé, Xian-Liang Li, Michèle Heslan, Claire Usal, Laurent Tesson, Séverine Ménoret, Abdelhadi Saoudi, Brigitte Le Mauff, Régis Josien, Maria Cristina Cuturi, Ignacio Anegon

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 2 6 2 4 6 3 6 4 6 2 6 5 4 4 5 2 4 6 1 78
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (78)

Title and authors Publication Year
Human pluripotent stem cell-derived hepatic progenitors exhibit a partially hypoimmunogenic phenotype and actively inhibit immune responses
Gantier M, Ménoret S, Fourrier A, Delbos F, Nguyen TH, Anegon I
Frontiers in Immunology 2025
A donor PD-1+CD8+ TSCM-like regulatory subset mobilized by G-CSF alleviates recipient acute graft-versus-host-disease
Liu D, Wang X, Han Y, Wang J, Sun Y, Hou Y, Wu Q, Zeng C, Ding X, Chang Y, Hu J, Huang X, Lu L
Signal Transduction and Targeted Therapy 2025
Pregnancy programs epigenetic hypofunction in memory CD8+ T cells
Jared Pollard, Grace Hynes, Dengping Yin, Malay Mandal, Fotini Gounari, Maria-Luisa Alegre, Anita Chong
JCI Insight 2024
Treg in inborn errors of immunity: gaps, knowns and future perspectives
Kennedy-Batalla R, Acevedo D, Luo Y, Esteve-Solé A, Vlagea A, Correa-Rocha R, Seoane-Reula ME, Alsina L
Frontiers in immunology 2024
Renal graft function in transplanted patients correlates with CD45RC T cell phenotypic signature
Bézie S, Sérazin C, Autrusseau E, Vimond N, Giral M, Anegon I, Guillonneau C
PloS one 2024
Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media
Khushbu Priya, Sonali Rawat, Doli Das, Manaswi Chaubey, Hiral Thacker, Kiran Giri, Shambhavi Singh, Madhukar Rai, Sujata Mohanty, Geeta Rai
Frontiers in immunology 2024
mRNA-delivery of IDO1 suppresses T cell-mediated autoimmunity.
Kenney LL, Chiu RS, Dutra MN, Wactor A, Honan C, Shelerud L, Corrigan JJ, Yu K, Ferrari JD, Jeffrey KL, Huang E, Stein PL
Cell reports. Medicine 2024
Analysis of frequency changes in CD8+ regulatory T cell subsets in peripheral blood of individuals with type 1 diabetes
Chen S, Meng G, Wang X, Jiang H, Shen M, Wang X, Wang C
Diabetology & Metabolic Syndrome 2024
CD4+ and CD8+ regulatory T cell characterization in the rat using a unique transgenic Foxp3-EGFP model
Ménoret S, Tesson L, Remy S, Gourain V, Sérazin C, Usal C, Guiffes A, Chenouard V, Ouisse LH, Gantier M, Heslan JM, Fourgeux C, Poschmann J, Guillonneau C, Anegon I
BMC Biology 2023
CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential.
Koh CH, Lee S, Kwak M, Kim BS, Chung Y
Experimental & molecular medicine 2023
Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges
Riet T, Chmielewski M
Frontiers in immunology 2022
IL‐34 deficiency impairs FOXP3+ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis
Freuchet A, Salama A, Bézie S, Tesson L, Rémy S, Humeau R, Règue H, Sérazin C, Flippe L, Peterson P, Vimond N, Usal C, Ménoret S, Heslan J, Duteille F, Blanchard F, Giral M, Colonna M, Anegon I, Guillonneau C
Clinical and Translational Medicine 2022
Neuroinflammation: extinguishing a blaze of T cells
Benallegue N, Kebir H, Alvarez JI
Immunological Reviews 2022
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells.
Benallegue N, Nicol B, Lasselin J, Bézie S, Flippe L, Regue H, Vimond N, Remy S, Garcia A, Le Frère F, Anegon I, Laplaud D, Guillonneau C
Neurology: Neuroimmunology & Neuroinflammation 2022
T Regulatory Cells in Human Health and Diseases
SG Zheng
2021
CD8+ T Lymphocytes: Crucial Players in Sjögren’s Syndrome
H Zhou, J Yang, J Tian, S Wang
Frontiers in immunology 2021
Genetic engineering of human and mouse CD4+ and CD8+ Tregs using lentiviral vectors encoding chimeric antigen receptors
N Vimond, J Lasselin, I Anegon, C Guillonneau, S Bézie
Molecular Therapy — Methods & Clinical Development 2021
The Complex Role of Regulatory T Cells in Immunity and Aging
L Rocamora-Reverte, FL Melzer, R Würzner, B Weinberger
Frontiers in immunology 2021
Overexpression of fibrinogen-like protein 2 alleviates acute rejection in rat models of liver transplantation
X Zhang, J Ma, H Li, L Zhou, Z Liu, S Lyu, Q He, X Li
Annals of translational medicine 2021
Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
L Xu, J Ling, C Su, YW Su, Y Xu, Z Jiang
Frontiers in Medicine 2021
Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome
Angela C Sosa, Barbara Kariuki, Qi Gan, Alan Knutsen, Clifford Bellone, Miguel A. Guzman, Luis Barrera, Shunji Tomatsu, Anil K Chauhan, Eric Armbrecht, Adriana M Montano
Journal of Clinical Investigation 2020
Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease
L Boucault, MD Robles, A Thiolat, S Bézie, M Schmueck-Henneresse, C Braudeau, N Vimond, A Freuchet, E Autrusseau, F Charlotte, R Redjoul, F Beckerich, M Leclerc, E Piaggio, R Josien, HD Volk, S Maury, JL Cohen, I Anegon, C Guillonneau
Blood Advances 2020
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
M Georganaki, M Ramachandran, S Tuit, NG Núñez, A Karampatzakis, G Fotaki, L van Hooren, H Huang, R Lugano, T Ulas, A Kaunisto, EC Holland, P Ellmark, SM Mangsbo, J Schultze, M Essand, S Tugues, A Dimberg
OncoImmunology 2020
Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice
S Bézie, B Charreau, N Vimond, J Lasselin, N Gérard, V Nerrière-Daguin, F Bellier-Waast, F Duteille, I Anegon, C Guillonneau
Blood Advances 2019
Future prospects for CD8 + regulatory T cells in immune tolerance
L Flippe, S Bézie, I Anegon, C Guillonneau
Immunological Reviews 2019
Alloactivation of Naïve CD4+CD8−CD25+T Regulatory Cells: Expression of CD8α Identifies Potent Suppressor Cells That Can Promote Transplant Tolerance Induction
ND Verma, CM Robinson, N Carter, P Wilcox, GT Tran, C Wang, A Sharland, M Nomura, KM Plain, GA Bishop, SJ Hodgkinson, BM Hall
Frontiers in immunology 2019
Role of indoleamine 2,3-dioxygenase in testicular immune-privilege
GS Gualdoni, PV Jacobo, CM Sobarzo, CV Pérez, ME Matzkin, C Höcht, MB Frungieri, M Hill, I Anegon, L Lustig, VA Guazzone
Scientific Reports 2019
Dendritic cells treated with exogenous indoleamine 2,3-dioxygenase maintain an immature phenotype and suppress antigen-specific T cell proliferation
E Bracho-Sanchez, A Hassanzadeh, MA Brusko, MA Wallet, BG Keselowsky
2019
Advances in the Study of CD8+ Regulatory T Cells.
Tang X, Kumar V
Critical reviews in immunology 2019
Description of CD8 + Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer
MR Vieyra-Lobato, J Vela-Ojeda, L Montiel-Cervantes, R López-Santiago, MC Moreno-Lafont
Journal of Immunology Research 2018
Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice
S Bézie, D Meistermann, L Boucault, S Kilens, J Zoppi, E Autrusseau, A Donnart, V Nerrière-Daguin, F Bellier-Waast, E Charpentier, F Duteille, L David, I Anegon, C Guillonneau
Frontiers in immunology 2018
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences
D Davar, N Bahary
Targeted Oncology 2018
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma
K Latha, J Yan, Y Yang, LV Gressot, LY Kong, G Manyam, R Ezhilarasan, Q Wang, EP Sulman, RE Davis, S Huang, GN Fuller, A Rao, AB Heimberger, S Li, G Rao
JNCI Journal of the National Cancer Institute 2018
Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells
Elodie Picarda, Séverine Bézie, Laetitia Boucault, Elodie Autrusseau, Stephanie Killens, Dimitri Meistermann, Bernard Martinet, veronique daguin, Audrey Donnart, Eric Charpentier, Laurent David, Ignacio Anegon, Carole Guillonneau
JCI Insight 2017
Immunoregulatory properties of the cytokine IL-34
C Guillonneau, S Bézie, I Anegon
Cellular and Molecular Life Sciences 2017
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
S Bézie, C Usal, C Guillonneau
Journal of visualized experiments : JoVE 2017
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy
P Kalinski
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy 2017
Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
Y Liu, X Liang, X Yin, J Lv, K Tang, J Ma, T Ji, H Zhang, W Dong, X Jin, D Chen, Y Li, S Zhang, HQ Xie, B Zhao, T Zhao, J Lu, ZW Hu, X Cao, FX Qin, B Huang
Nature Communications 2017
Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats
S Hamdani, A Thiolat, S Naserian, C Grondin, S Moutereau, A Hulin, J Calderaro, P Grimbert, JL Cohen, D Azoulay, C Pilon
World journal of gastroenterology : WJG 2017
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
DH Munn, AL Mellor
Trends in Immunology 2016
Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
A Buqué, N Bloy, F Aranda, I Cremer, A Eggermont, WH Fridman, J Fucikova, J Galon, R Spisek, E Tartour, L Zitvogel, G Kroemer, L Galluzzi
OncoImmunology 2016
Transplant tolerance: a new role for IL-34
James Kim, Laurence A. Turka
Journal of Clinical Investigation 2015
Interleukin-34, a new Treg-specific cytokine mediator of transplant tolerance
Séverine Bézie, Elodie Picarda, Jason Ossart, Laurent Tesson, Claire Usal, Karine Renaudin, Ignacio Anegon, Carole Guillonneau
Journal of Clinical Investigation 2015
The Evolving Roles of Memory Immune Cells in Transplantation:
W Chen, RM Ghobrial, XC Li
Transplantation 2015
Fibrinogen-Like Protein 2/Fibroleukin Induces Long-Term Allograft Survival in a Rat Model through Regulatory B Cells
S Bézie, E Picarda, L Tesson, K Renaudin, J Durand, S Ménoret, E Mérieau, E Chiffoleau, C Guillonneau, L Caron, I Anegon, L Chatenoud
PloS one 2015
Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation
AJ Ligocki, JY Niederkorn
Transplantation 2015
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
YW Moon, J Hajjar, P Hwu, A Naing
Journal for ImmunoTherapy of Cancer 2015
Central memory CD8+ T lymphocytes mediate lung allograft acceptance
Alexander Krupnick, Xue Lin, WenJun Li, Ryuji Higashikubo, Bernd Zinselmeyer, Hollyce Hartzler, Kelsey Toth, Jon Ritter, Mikhail Berezin, Steven Wang, Mark Miller, Andrew Gelman, Daniel Kreisel
Journal of Clinical Investigation 2014
MHC-derived allopeptide recognized by TCR biased-CD8+ Tregs suppresses organ rejection
Elodie Picarda, Séverine Bézie, Vanessa Venturi, Klara Echasserieau, Emmanuel Merieau, Aurélie Delhumeau, Karine Renaudin, Sophie Brouard, Karine Bernardeau, Ignacio Anegon, Carole Guillonneau
Journal of Clinical Investigation 2014
Trial watch: IDO inhibitors in cancer therapy
E Vacchelli, F Aranda, A Eggermont, C Sautès-Fridman, E Tartour, EP Kennedy, M Platten, L Zitvogel, G Kroemer, L Galluzzi
OncoImmunology 2014
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma
M Li, AR Bolduc, MN Hoda, DN Gamble, SB Dolisca, AK Bolduc, K Hoang, C Ashley, D McCall, AM Rojiani, BL Maria, O Rixe, TJ MacDonald, PS Heeger, AL Mellor, DH Munn, TS Johnson
Journal for ImmunoTherapy of Cancer 2014
The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells
S Trabanelli, D Ocadlikova, M Ciciarello, V Salvestrini, M Lecciso, C Jandus, R Metz, C Evangelisti, L Laury-Kleintop, P Romero, GC Prendergast, A Curti, RM Lemoli
Journal of immunology (Baltimore, Md. : 1950) 2014
Effector Mechanisms of Rejection
A Moreau, E Varey, I Anegon, MC Cuturi
Cold Spring Harbor Perspectives in Medicine 2013
A Higher Risk of Acute Rejection of Human Kidney Allografts Can Be Predicted from the Level of CD45RC Expressed by the Recipients’ CD8 T Cells
L Ordonez, I Bernard, M Chabod, JF Augusto, V Lauwers-Cances, C Cristini, MC Cuturi, JF Subra, A Saoudi, K Tasken
PloS one 2013
Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?
BM Hall, GT Tran, ND Verma, KM Plain, CM Robinson, M Nomura, SJ Hodgkinson
Frontiers in immunology 2013
Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses
MS Poormasjedi-Meibod, RB Jalili, A Hosseini-Tabatabaei, R Hartwell, A Ghahary
PloS one 2013
Altered Tryptophan Metabolism as a Paradigm for Good and Bad Aspects of Immune Privilege in Chronic Inflammatory Diseases
L Li, L Huang, HP Lemos, M Mautino, AL Mellor
Frontiers in immunology 2012
Molecular cloning and characterization of porcine indoleamine 2, 3-dioxygenase and its expression in various tissues
C Chen, M Wei, L Wang, Y Xiang, X Fu, M Zhu
Journal of Huazhong University of Science and Technology [Medical Sciences] 2012
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
DH Munn, AL Mellor
Trends in Immunology 2012
Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions
G Chen, T Kheradmand, J Bryant, S Wang, J Tasch, JJ Wang, Z Zhang, X Luo
American Journal of Transplantation 2012
Making Sense of Regulatory T Cell Suppressive Function
I Shalev, M Schmelzle, SC Robson, G Levy
Seminars in Immunology 2011
Common Gamma Chain Cytokines Promote Rapid In Vitro Expansion of Allo-Specific Human CD8+ Suppressor T Cells
Y Yu, JR Zitzner, J Houlihan, N Herrera, L Xu, J Miller, JM Mathew, AR Tambur, X Luo
PloS one 2011
IDO and Regulatory T Cell Support Are Critical for Cytotoxic T Lymphocyte-Associated Ag-4 Ig-Mediated Long-Term Solid Organ Allograft Survival
R Sucher, K Fischler, R Oberhuber, I Kronberger, C Margreiter, R Ollinger, S Schneeberger, D Fuchs, ER Werner, K Watschinger, B Zelger, G Tellides, N Pilat, J Pratschke, R Margreiter, T Wekerle, G Brandacher
Journal of immunology (Baltimore, Md. : 1950) 2011
Immunosuppressive role of fibrinogen-like protein 2 (FGL2) in CD8+regulatory T cells-mediated long-term graft survival
Bézie S, Ménoret S, Tesson L, Li XL, Usal C, Anegon I, Caron L
Journal of Translational Medicine 2011
Alloantigenic recognition properties of CD8+ regulatory T cells
Picarda E, Anegon I, Guillonneau C
Journal of Translational Medicine 2011
Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege
L Huang, B Baban, BA Johnson, AL Mellor
International Reviews of Immunology 2010
Tumor vaccines and beyond
JOSEPH MELENHORST J, JOHN BARRETT A
Cytotherapy 2010
Novel CD8+Treg suppress EAE by TGF-β- and IFN-γ-dependent mechanisms
ML Chen, BS Yan, D Kozoriz, HL Weiner
European Journal of Immunology 2009
IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses
SM Coley, ML Ford, SC Hanna, ME Wagener, AD Kirk, CP Larsen
Journal of immunology (Baltimore, Md. : 1950) 2009
Dendritic Cells
G Lombardi, Y Riffo-Vasquez
Dendritic Cells 2009
Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy
BA rd, B Baban, AL Mellor
Immunotherapy 2009
Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-gamma
EY Kim, HH Chi, M Bouziane, A Gaur, KD Moudgil
Clinical Immunology 2008
Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells
G Feng, W Gao, TB Strom, M Oukka, RS Francis, KJ Wood, A Bushell
European Journal of Immunology 2008
Emerging concepts in CD8(+) T regulatory cells
JY Niederkorn
Current Opinion in Immunology 2008
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice
BJ Skaggs, RP Singh, BH Hahn
Human Immunology 2008
The effects of tolerance on allograft damage caused by the innate immune system
R Hoerbelt, CL Benjamin, T Shoji, SL Houser, A Muniappan, RS Hasse, LG Ledgerwood, JS Allan, DH Sachs, JC Madsen
Transplantation 2008
Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous FasL Protein
Yolcu ES, Gu X, Lacelle C, Zhao H, Bandura-Morgan L, Askenasy N, Shirwan H
Journal of immunology (Baltimore, Md. : 1950) 2008
Yin and Yang interplay of IFN-gamma in inflammation and autoimmune disease
Jingwu Zhang
Journal of Clinical Investigation 2007

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 14 patents
41 readers on Mendeley
See more details